UPDATE 1-3SBio, DaVita form JV in China for dialysis treatment

March 8 (Reuters) - Chinese biotechnology company 3SBio Inc and dialysis treatment provider DaVita Inc formed a joint venture to provide kidney care services in two provinces in northeastern China, the companies said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.